22^nd Annual European Pharma Congress

Nanomedicines

Submit Abstract Register Now

Nanomedicine is simply the nanotechnology applications in a healthcare setting and the majority of benefits that have already been seen involve the use of nanoparticles to improve the behaviour of drug substances and in drug delivery. Today, nanomedicines are used globally to improve the treatments and lives of patients suffering from a range of disorders including ovarian and breast cancer, kidney disease, fungal infections, elevated cholesterol,menopausal symptoms, multiple sclerosis, chronic pain, asthma and emphysema. Nanomedicine has the potential to develop radical new therapies based on an unprecedented control over both intracellular processes and the extracellular environment at the nanometer scale. To create precise solutions for intricate medical challenges in the area of wound healing, tissue regeneration and mitochondrial disease physical scientists, medical doctors, and industrial partners, work closely in the Radboud Nanomedicine Alliance. The National Nanotechnology Initiative expects new commercial applications in the pharmaceutical industry that may include advanced delivery systems, new therapies, and in vivo imaging.

• Scope of Nanomedicine
• Future aspects of Nanomedicine
• Nanomedicine for Cardiovascular Diseases
• Nanomedicine for Lung Diseases
• Nanomedicine for blood disorders
• Nanomedicine for CNS
• Nanomedicine for Gastrointestinal Tract (GI) Diseases
• Nanomedicine for other disease
• Novel Drugs to Nano Drugs
• Nanodrugs for Herbal medicines and Cosmetics